Inhibition of vessel allograft rejection by endothelial removal

M. A. Galumbeck, F. P. Sanfilippo, O. Hagen, A. V. Seaber, J. R. Urbaniak

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


The vascular endothelium plays an important and complex role in vascular allograft rejection. Antigens expressed by the endothelium can act to promote and be the target of rejection reactions, which often lead to thrombosis and ischemic necrosis of the allograft. In this study, segments of femoral artery and femoral vein with or without endothelium were grafted between allogenic or autologous control rats. Immunocompetent Lewis (RT11) recipient rats were randomly selected for groups (N=14 for each) receiving the following: ACI- (RT1a) allografts with intact endothelium, allografts with endothelium removed before operation, autografts with endothelium, and autografts with endothelium removed. Rejection was assessed by graft patency as well as morphologic and ultrastructural changes. At 5 days, the allografts with intact endothelium were totally occluded, whereas allografts without endothelium remained patent, as did autologous control grafts with or without endothelium. Two additional groups (N= 14 each) receiving the de-endothelialized allografts or autografts were examined at 120 days after operation, revealing that grafts in both groups were still patent and had been re-endothelialized. These findings indicate that physical removal of vascular endothelium may depress vessel allograft rejection without immunosuppressive therapy.

Original languageEnglish (US)
Pages (from-to)757-764
Number of pages8
JournalAnnals of Surgery
Issue number6
StatePublished - 1987
Externally publishedYes

ASJC Scopus subject areas

  • Surgery


Dive into the research topics of 'Inhibition of vessel allograft rejection by endothelial removal'. Together they form a unique fingerprint.

Cite this